scholarly article | Q13442814 |
P2093 | author name string | Buchanan TA | |
Gonzalez M | |||
Wu PY | |||
Kjos SL | |||
Xiang A | |||
Madrilejo NG | |||
Montoro MN | |||
Nunez V | |||
Pantoja PM | |||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | gestational diabetes | Q126691 |
P304 | page(s) | 275-283 | |
P577 | publication date | 1994-04-01 | |
P1433 | published in | Diabetes Care | Q5270111 |
P1476 | title | Use of fetal ultrasound to select metabolic therapy for pregnancies complicated by mild gestational diabetes | |
P478 | volume | 17 |
Q84968707 | A special case of gestational diabetes mellitus |
Q44684233 | A thirty-year analysis of cesarean section rate in gestational diabetes and normal pregnant population in Tehran, Iran: a concerning trend |
Q47223568 | Abdominal circumference vs. estimated weight to predict large for gestational age birth weight in diabetic pregnancy |
Q44444530 | Amniotic fluid insulin levels and fetal abdominal circumference at time of amniocentesis in pregnancies with diabetes |
Q73785627 | Arrest of descent in second stage of labour secondary to macrosomia: a case report |
Q37015599 | Comparison of maternal and fetal outcomes among Asian Indian pregnant women with or without gestational diabetes mellitus: A situational analysis study (WINGS-3) |
Q35540108 | Diet plus insulin compared to diet alone in the treatment of gestational diabetes mellitus: a systematic review |
Q33842357 | Dysglycemias in pregnancy: from diagnosis to treatment. Brazilian consensus statement. |
Q44956783 | Flexible treatment of gestational diabetes modulated on ultrasound evaluation of intrauterine growth: a controlled randomized clinical trial |
Q40627538 | Gestational diabetes in the United States: temporal changes in prevalence rates between 1979 and 2010. |
Q33683791 | Gestational diabetes mellitus |
Q44990541 | Gestational diabetes mellitus--implications of different treatment protocols |
Q37458841 | Gestational diabetes mellitus: developments in diagnosis and treatment |
Q35505266 | Gestational diabetes mellitus: risks and management during and after pregnancy. |
Q33886825 | Glycemic control in the diabetic pregnancy: is tighter always better? |
Q38268269 | Glycemic targets in pregnancies affected by diabetes: historical perspective and future directions |
Q34421889 | How Many Sonograms Are Needed to Reliably Predict the Absence of Fetal Overgrowth in Gestational Diabetes Mellitus Pregnancies? |
Q52995169 | Hyperinsulinism, neonatal obesity and placental immaturity in infants born to women with one abnormal glucose tolerance test value. |
Q42772077 | Management of gestational diabetes |
Q45774073 | Prediction of large for gestational age birth weights in diabetic mothers based on early third-trimester sonography |
Q77098028 | Pregnancy in diabetes |
Q92527620 | Pregnancy outcome of Japanese patients with glucokinase-maturity-onset diabetes of the young |
Q48718070 | Pregnancy outcome of gestational diabetes mellitus using a structured model of care : WINGS project (WINGS-10). |
Q51533999 | Relationship between sonographically estimated fetal subcutaneous adipose tissue measurements and neonatal skinfold measurements. |
Q89566235 | Research Gaps in Gestational Diabetes Mellitus: Executive Summary of a National Institute of Diabetes and Digestive and Kidney Diseases Workshop |
Q42419524 | Response to Comment on: Chakera et al. Antenatal diagnosis of fetal genotype determines if maternal hyperglycemia due to a glucokinase mutation requires treatment. Diabetes Care 2012;35:1832-1834 |
Q28360761 | Screening for diabetes in pregnancy |
Q35102651 | Self-monitoring of blood glucose in gestational diabetes |
Q92313867 | The Utility of Lower Glycemic Targets for Treating Gestational Diabetes: A Retrospective Study |
Q35093319 | The offspring of gestational diabetes |
Q39969012 | The prevalence of hyperglycaemia in pregnancy in Australia |
Q34612283 | The principles of dietary management of gestational diabetes: reflection on current evidence |
Q37951995 | The use of pharmacotherapy in pregnancies with suspected diabetic fetopathy |
Q39460823 | Translation of fetal abdominal circumference-guided therapy of gestational diabetes complicated by maternal obesity to a clinical outpatient setting |
Q24239906 | Treatments for gestational diabetes |
Q24247989 | Treatments for gestational diabetes and impaired glucose tolerance in pregnancy |
Q44446429 | Twin pregnancy outcomes for women with gestational diabetes mellitus compared with glucose tolerant women |
Q37259239 | Ultrasound (in)accuracy: it's in the formulae not in the technique - assessment of accuracy of abdominal circumference measurement in term pregnancies |
Q53761965 | Ultrasound biometry evolves in the management of diabetes in pregnancy. |
Q73516448 | Ultrasound growth parameters in relation to levels of amniotic fluid insulin in women with diabetes type-I |
Q38174141 | Ultrasound-guided compared to conventional treatment in gestational diabetes leads to improved birthweight but more insulin treatment: systematic review and meta-analysis |
Q47618310 | Very tight versus tight control: what should be the criteria for pharmacologic therapy dose adjustment in diabetes in pregnancy? Evidence from randomized controlled trials |
Q38683831 | What is the accuracy of an early third trimester sonogram for identifying LGA infants born to GDM patients diagnosed with the one-step approach? |
Q37583688 | What is the value of ultrasound soft tissue measurements in the prediction of abnormal fetal growth? |
Q43923280 | When and how to start insulin treatment in gestational diabetes: a UK perspective |
Q34957940 | When diet fails: insulin and oral hypoglycemic agents as alternatives for the management of gestational diabetes mellitus |
Q83030422 | [Obstetrical care in gestational diabetes and management of preterm labor] |
Search more.